Featured Latest News

Piramal Pharma Bets On Complex Drugs To Drive Future Growth

By Uniquetimesorg April 29, 2026 0

Piramal Pharma is aiming to boost earnings over the next two to three years by focusing on rising demand for complex drugs, particularly targeted cancer therapies. Chairperson Nandini Piramal said the company expects stronger growth as global interest in advanced treatments increases, especially in high-value segments like antibody-drug conjugates (ADCs). The company Continue Reading

Featured Latest news

Chronic Diseases Drive 40% of India Pharma Market

By Uniquetimesorg April 23, 2026 0

India’s pharmaceutical market continued its strong growth trajectory in March 2026, expanding 10.7% year-on-year, driven largely by rising demand for treatments targeting chronic conditions. According to data from IQVIA and Equirus Securities, diseases such as hypertension, diabetes and high cholesterol now account for over 40% of the total market, reflecting a steady Continue Reading

Featured Latest News

India Inspects 90% of Cough Syrup Units, Finds Compliance Gaps

By Uniquetimesorg February 23, 2026 0

India’s drug regulator has inspected nearly 90% of the country’s cough syrup manufacturers and uncovered multiple compliance lapses, according to Drugs Controller General of India Rajeev Raghuvanshi. Speaking at the 11th Global Pharmaceutical Quality Summit in Mumbai, he said strict action had been taken against serious violations. The inspections follow heightened Continue Reading

Featured Latest news

Sanofi to Expand Hyderabad GCC, Workforce to Cross 4,500

By Uniquetimesorg February 17, 2026 0

French drugmaker Sanofi announced plans to expand its global capability centre (GCC) in Hyderabad, increasing its workforce to more than 4,500 employees from the current 2,600. The expansion will be backed by a multi-hundred-million-dollar investment, though the company did not disclose a specific timeline for hiring. In 2024, Sanofi had committed to investing 400 million Continue Reading

Featured Latest News

Alkem’s MedTech Arm to Acquire 55% of Occlutech

By Uniquetimesorg February 13, 2026 0

Alkem Laboratories said its medical devices subsidiary will acquire up to a 55% stake in Switzerland-based Occlutech Holding AG for 99.4 million euros (about $118 million), marking its entry into advanced cardiovascular devices. The transaction, expected to close by June 2026 subject to regulatory approvals and final agreements, will expand Alkem MedTech’s presence in Continue Reading

Featured Latest News

Sun Pharma Launches Breakthrough Psoriasis Drug Ilumya in India

By Uniquetimesorg December 1, 2025 0

Sun Pharmaceutical Industries has introduced its blockbuster biologic therapy Ilumya (Tildrakizumab) in India, marking a major step toward expanding access to advanced treatments for moderate-to-severe plaque psoriasis. Known for selectively targeting IL-23, Ilumya has already made its mark across 35 global markets, including the United States, and is now set to benefit Continue Reading